Identification of Immune-Mediated Causes of Sensorineural Hearing Loss (R21/R33)

The summary for the Identification of Immune-Mediated Causes of Sensorineural Hearing Loss (R21/R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Identification of Immune-Mediated Causes of Sensorineural Hearing Loss (R21/R33): Purpose. The purpose of this FOA is to encourage submission of milestone-driven interdisciplinary Exploratory/Developmental Phased Innovation (R21/R33) research proposals designed to further our understanding of the mechanism, etiology, and pathophysiology of immune mediated sensorineural hearing loss (IMSNHL). Applications considered responsive include studies of 1) ear organ-specific autoimmune sensorineural hearing loss - i.e. autoimmune inner ear disease (AIED), 2) sudden sensorineural hearing loss attributable to AIED, as well as 3) sensorineural hearing loss associated with systemic autoimmune disease. Proposals primarily involving human subjects/tissues will be given highest priority. The human health goal of this FOA is the ultimate translation of the research findings into clinical biomarkers, new diagnostic tests with high sensitivity, specificity and positive predictive value, and the development of therapies that preserve natural hearing. Mechanism of Support. This FOA will utilize the R21/R33 Exploratory/Developmental Phased Innovation grant mechanism. Funds Available and Anticipated Number of Awards. NIDCD has set aside $700K in FY2011 and $1.3M in FY2012 in anticipation of 2-3 awards per application cycle.

Federal Grant Title:	Identification of Immune-Mediated Causes of Sensorineural Hearing Loss (R21/R33)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DC-11-002
Type of Funding:	Grant
CFDA Numbers:	93.173
CFDA Descriptions:	Research Related to Deafness and Communication Disorders
Current Application Deadline:	Jun 08, 2011
Original Application Deadline:	Jun 08, 2011
Posted Date:	Aug 18, 2010
Creation Date:	Aug 18, 2010
Archive Date:	Jul 09, 2011
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Medical Rehabilitation Research Resource (P50 Clinical Trial Optional); • Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Tr...; • BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Centr...; • NIDCD Patient-Oriented Research Grant (R21); • Cell Lineage and Developmental Studies in Hearing and Balance; • Structural Analyses of the Ligand-Binding Properties of Taste and Smell Receptors
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...